EUVIMEDEUVIMED entdecken
Crossref

Diagnostic performance of serum sterols, including oxysterols, for identifying cerebrotendinous xanthomatosis and monitoring treatment efficacy

Rieko Sagara, Satoshi Hirayama, Yoshifumi Fukushima, Tsuyoshi Ueno, Naoko Kuwabara, Saori Nakagawa, Hayato Tada, Shingo Koyama, Kazuyuki Noda, Minoru Takemoto, Tomoyo Hashimoto, Yukio Iwanaka und 5 weitere

Journal of Clinical Lipidology · 2026-09 · 20 (9) · 1840-1849

DOI: 10.1016/j.jacl.2026.06.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-09. Verfasst von Rieko Sagara und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan (Sagara, Hirayama, Fukushima, Ueno, and Mii…. Hauptthemen laut MEDLINE: Xanthomatosis, Cerebrotendinous, Oxysterols, Sterols. Die Arbeit nennt 38 Literaturangaben. Gefördert von: The Japan Society for Aeronautical and Space Sciences, Social and Cultural Affairs Welfare Foundation, Government of Japan Ministry of Education Culture Sports Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cerebrotendinous xanthomatosis (CTX) is caused by biallelic mutations in the CYP27A1 gene, which encodes sterol 27-hydroxylase. Reduced activity of this enzyme decreases bile acid synthesis and increases cholestanol production. Cholestanol, a metabolic intermediate, can be used as a diagnostic marker; however, patients with CTX have been reported to have normal cholestanol levels. Cholesterol and bile acid metabolism is likely to be extensively disrupted even in these patients with CTX. OBJECTIVE: We aimed to clarify whether sterol markers, including oxysterols, can be used to screen for and diagnose CTX and assess treatment efficacy. METHODS: Fourteen patients with CTX (homozygotes, n = 7; compound heterozygotes, n = 5; unidentified, n = 2), 6 carriers, and 24 healthy controls were enrolled. We analyzed 9 sterol markers, including 4 oxysterols, using gas chromatography-mass spectrometry. We measured these markers in patients with CTX before and after treatment with chenodeoxycholic acid (CDCA) and/or lipid-lowering agents. RESULTS: Cholestanol and sterol markers of cholesterol synthesis and absorption were 1.3 to 8.3 times higher in patients with CTX than in carriers and controls. These marker levels decreased significantly in patients with CTX after treatment. Compared to carriers and controls, patients with CTX had extremely low levels of 27-hydroxycholesterol (27-OHC) and extremely high levels of 7α-hydroxycholesterol (7α-OHC). During treatment, 7α-OHC levels decreased significantly, while 27-OHC levels remained low. Receiver operating characteristic analysis demonstrated excellent diagnostic performance. The area under the curve was 1.000 for low 27-OHC and 0.991 for elevated 7α-OHC, outperforming cholestanol (0.903). CONCLUSION: Sterol markers, including oxysterols, can be used to screen for and diagnose CTX and to assess treatment efficacy with CDCA and/or lipid-lowering agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xanthomatosis, CerebrotendinousOxysterolsSterolsHumansFemaleMaleAdultTreatment OutcomeBiomarkersChenodeoxycholic AcidCholestanetriol 26-MonooxygenaseMiddle AgedAdolescentCholestanolYoung AdultHydroxycholesterolsChildGas Chromatography-Mass SpectrometryROC CurveCase-Control Studies

Stichwörter der Autor:innen

27-hydroxycholesterol7-ketocholesterol7α-hydroxycholesterol7β-hydroxycholesterolChenodeoxycholic acidCholestanolOxysterol

Substanzen

OxysterolsSterolsBiomarkersChenodeoxycholic AcidCholestanetriol 26-MonooxygenaseCholestanolHydroxycholesterols

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan (Sagara, Hirayama, Fukushima, Ueno, and Miida).
  • Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan (Sagara, Hirayama, Fukushima, Ueno, and Miida); Health Service Center, Tokyo Gakugei University, Koganei, Japan (…
  • Niigata Agro-Food University, Niigata, Japan (Kuwabara); Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan (Kuwabara and Nakagawa).
  • Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan (Kuwabara and Nakagawa); Department of Clinical Engineering and Medical Technology, Niigata University of Health and Welfare, Niigata, Japan (…
  • Department of Cardiology, Kanazawa University, Graduate School of Medical Sciences, Kanazawa, Japan (Tada).
  • Division of Neurology and Clinical Neuroscience, Department of Internal Medicine III, Yamagata University Faculty of Medicine, Yamagata, Japan (Koyama); National Hospital Organization Yamagata National Hospital, Yamagat…

Förderung

  • The Japan Society for Aeronautical and Space Sciences
  • Social and Cultural Affairs Welfare Foundation
  • Government of Japan Ministry of Education Culture Sports Science and Technology

Zitieren

APA

Sagara, R., Hirayama, S., Fukushima, Y., Ueno, T., Kuwabara, N., Nakagawa, S., Tada, H., Koyama, S., Noda, K., Takemoto, M., Hashimoto, T., Iwanaka, Y., Adachi, H., Higashi, Y., Sekijima, Y., Miida, T., & research group for diagnostic markers of cerebrotendinous xanthomatosis (2026). Diagnostic performance of serum sterols, including oxysterols, for identifying cerebrotendinous xanthomatosis and monitoring treatment efficacy. Journal of Clinical Lipidology, 20(9), 1840-1849. https://doi.org/10.1016/j.jacl.2026.06.021

Vancouver

Sagara R, Hirayama S, Fukushima Y, Ueno T, Kuwabara N, Nakagawa S, et al. Diagnostic performance of serum sterols, including oxysterols, for identifying cerebrotendinous xanthomatosis and monitoring treatment efficacy. Journal of Clinical Lipidology. 2026;20(9):1840-1849. doi:10.1016/j.jacl.2026.06.021

BibTeX
@article{Sagara2026,
  author = {Sagara, Rieko and Hirayama, Satoshi and Fukushima, Yoshifumi and Ueno, Tsuyoshi and Kuwabara, Naoko and Nakagawa, Saori and Tada, Hayato and Koyama, Shingo and Noda, Kazuyuki and Takemoto, Minoru and Hashimoto, Tomoyo and Iwanaka, Yukio and Adachi, Hiroaki and Higashi, Yukihito and Sekijima, Yoshiki and Miida, Takashi and research group for diagnostic markers of cerebrotendinous xanthomatosis, research group for diagnostic markers of cerebrotendinous xanthomatosis},
  title = {Diagnostic performance of serum sterols, including oxysterols, for identifying cerebrotendinous xanthomatosis and monitoring treatment efficacy},
  journal = {Journal of Clinical Lipidology},
  year = {2026},
  volume = {20},
  number = {9},
  pages = {1840--1849},
  doi = {10.1016/j.jacl.2026.06.021}
}
Kostenlos starten →